ObjectiveThere is emerging evidence for CD8 + T cell alterations in blood from patients with coronary artery disease (CAD). We examined whether the distribution and phenotype of CD8 + CD56 + T cells differed according to the clinical manifestation of CAD.
MethodsPatients with acute coronary syndrome (ACS, n=30), stable angina (SA, n=34) and controls (n=36) were included. Blood was collected before and up to 12 months after referral for coronary investigation. CD8 + CD56 + T cells were assessed by flow cytometry for expression of surface markers, apoptosis, and intracellular expression of cytokines.
ResultsThe proportions of CD8 + CD56 + T cells were significantly higher in both ACS and SA patients compared with controls, and remained so after 3 and 12 months. This was independent of age, sex, systemic inflammation and cytomegalovirus seropositivity.
ConclusionThe persistent accumulation of CD8 + CD56 + T cells in ACS and SA patients share several features with immunological aging. It also contributes to a larger IFN-γ + pool in blood, and may thereby hypothetically drive the atherosclerotic process in a less favorable direction.